APOE and cancer: In a study of fall prevention exercise in post-treatment female cancer survivors aged 50–75 years old (ClinicalTrials.gov NCT01635413), the APOE genotype modulated cancer treatment-related side effects and symptoms and response to exercise intervention [21].